GOCL Corporation's appeal allowed by NCLAT to proceed Scheme meeting process
GOCL Corporation Ltd · Chemicals & Petrochemicals
What the filing says
- NCLAT, on September 25, 2026, set aside NCLT's July 30, 2026 order dismissing Scheme application
- NCLAT directed NCLT to appoint chairman, scrutinizers, fix remuneration, and schedule meetings by October 5, 2026
- Scheme involves merger of Hinduja National Power Corporation Limited into GOCL Corporation Limited under Sections 230-232 Companies Act, 2013
Why it's rated notable: merger demerger is always high
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Order From National Company Law Appellate Tribunal Dated September 25, 2026
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from GOCL Corporation Ltd
- Financial resultsMajor developmentGOCL Corporation Limited approves results for quarter ended September 30, 2026
- Order winNotableGOCL Corporation received NCLT order to convene meetings for merger approval
Other acquisition / merger filings this fortnight
- Sudarshan Europe B.V. discloses substantial acquisition in Heubach Colorants India Ltd
- Sagility Limited acquires Chirok Health to expand provider-focused services
- Dr. Agarwal’s Eye Hospital Ltd approves Scheme of Amalgamation effective Nov 1, 2026
- Shrem InvIT manager's board approves up to INR 1,046 crore NaBFID term loan
- Dr. Agarwal's Health Care board notes amalgamation scheme effective Nov 1, 2026
- Kwality Pharmaceuticals acquires 4 acres for manufacturing expansion in Amritsar
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.